Get In Touch
Tmapril cpver 104x80.jpg
Current Issue
section
logo
  • animation-product-ttg-729x90' width='728' height='90' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0
  • tyroliteautomotive' width='728' height='90' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0' border='0

Clariant breaks ground for new packaging plant in Cuddalore

By Niranjan Mudholkar,

Added 25 January 2016

Strengthening of global manufacturing footprint and customer proximity in Asia; plant expected to be operational by 2017.

Clariant, a world leader in specialty chemicals, performed the groundbreaking ceremony of a new manufacturing plant in Cuddalore, for moisture-control products, intended for the pharma industry.

In December 2015, Clariant had announced plans to invest CHF 10 million in this Healthcare Packaging plant, that will support the growing generic pharmaceutical industry in India. The investment will be implemented through its wholly owned subsidiary in India.

"The new Healthcare Packaging manufacturing plant here in Cuddalore is another important step within our strategy to intensify growth and increase our market share in the emerging India region by rapidly addressing customer needs," said Christian Kohlpaintner, member of the Clariant Executive Committee.

The new plant will initially produce desiccant canisters and packets, which are inserted into pharmaceutical packaging to control moisture and protect the stability of the medicine during shelf life. The desiccant production area will be Clean Room Class 100,000 and certified ISO 8. It will be compliant with all relevant cGMP and US FDA standards.

(Continued on the next page)

comments powered by Disqus